Denning, C.R. , Bruce, G.M., and Spalter, H.F.: Optic neuritis in chloramphenicol-treated patients with cystic fibrosis. J. Pediatr.63: 878, 1963 (Abstr.).
2.
Huang, N.N., Promadhattavedi, S., and Sproul, A.: Long-term therapy with chloramphenicol and optic neuritis in patients with cystic fibrosis. Abstract 169, Third Interscience Conference on Antimicrobial Agents and Chemotherapy, 1963, p. 79.
3.
Harley, R.D. , Huang, N.N., Marcri, C.H., et al.: Optic neuritis and optic atrophy following chloramphenicol in cystic fibrosis patients. Trans. Am. Acad. Opthamol. Otolaryngol.74: 1011, 1970.
Lloyd, A.V.C. , Grimes, G., and Khaw, K.T.: Chloramphenicol for long-term therapy of cystic fibrosis. JAMA814: 1001, 1963.
6.
Shwachman, H. , Redmond, A., and Khaw, K.T.: Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20 year period. Pediatrics46: 335, 1970.
7.
Yunis, A.A.: Chloramphenicol-induced bone marrow suppression. Semin. Hematol.10: 225, 1973.
8.
McCurdy, P.R. : Chloramphenicol bone marrow toxicity. JAMA176: 588, 1961.
9.
Weisberger, A.S.: Mechanisms of action of chloramphenicol . JAMA209: 97, 1969.
10.
Ambrose, C.T. , and Coons, A.H.: Studies on antibody production. VIII. The inhibitory effect of chloramphenicol on the synthesis of antibody in tissue culture. J. Exp. Med.117: 1075, 1963.
11.
Daniel, T.M. , Suhrland, L.G., and Ewisberger , A.S.: Suppression of the anamnestic response to tetanus toxoid in May by chloramphenicol. N. Engl. J. Med.273: 367, 1965.
12.
Saidi, P., Wallenstein, R., and Aggeler, P.: Effect of chloramphenicol on erythropoiesis. J. Lab. Clin. Med.57: 247, 1961.